期刊文献+

坎地沙坦酯对鱼藤酮致帕金森病大鼠的保护作用 被引量:2

Protective effect of candesartan cilexetil on rotenone-induced Parkinson's disease in rats
原文传递
导出
摘要 目的 研究坎地沙坦酯对鱼藤酮致帕金森病(PD)大鼠的影响. 方法 10周龄雄性Lewis大鼠40只按照随机数字表法分为对照组、鱼藤酮组、鱼藤酮+坎地沙坦酯组和坎地沙坦酯组,每组10只.100 g/L水合氯醛麻醉充分后,微量渗透泵包埋于各组大鼠背部皮下.鱼藤酮[2.5~3.0 mg/(kg· d)]溶于二甲基亚砜和聚乙二醇(1∶1)混合液中,埋于鱼藤酮组大鼠微量渗透泵中;余3组给予等质量的生理盐水装于微量渗透泵中;鱼藤酮+坎地沙坦酯组大鼠同时给予坎地沙坦酯(混于0.5%甲基纤维素中)每天上午8时~12时灌胃[1 mg/(kg· d)],对照组给予等体积生理盐水灌胃.行为学检测评定运动功能等损害症状;免疫组化染色检测大鼠黑质部位酪氨酸羟化酶(TH)和α-共核蛋白表达情况;Western blotting检测黑质部位α-共核蛋白表达水平. 结果 分组4周后鱼藤酮组大鼠体质量明显减轻,降至(297.3±12.2)g;黑质部位TH阳性细胞显著减少,降至(377.0±41.6)个/mm2;α-共核蛋白表达显著增加,达到0.75±0.02;鱼藤酮+坎地沙坦酯组对应的各项值分别为(337.2±26.3)g、(639.7 ±46.0)个/mm2、0.57±0.01;二者差异有统计学意义(P<0.05).Western blotting结果与之一致. 结论 坎地沙坦酯能够通过减少TH阳性细胞凋亡及α-共核蛋白沉积起到保护PD大鼠作用. Objective To investigate the effect of candesartan cilexetil on rotenone-induced Parkinson's disease (PD) in rats.Methods Forty 10-week-old male Lewis rats were chosen in our study and equally randomized into control group,rotenone group,rotenone+candesartan cilexetil group and candesartan cilexetil group (n=10); rotenone (2.5-3.0 mg/[kg· d]) was given for 4 weeks to the rats of rotenone group and rotenone+candesartan cilexetil group by subcutaneous osmotic minipumps implantation under the back; rats in the rotenone+candesartan cilexetil group and candesartan cilexetil group were orally administered candesartan cilexetil.Neurological behavioral measurements were performed to evaluate the motor features; tyrosine hydroxylase (TH) and α-synuclein immunoreactivities in the substantia nigra pars compacta (SNc) were observed.Protein level of α-synuclein was determined by Westem blotting.Results The weight of rats in the rotenone group reduced to (297.3±12.2) g,with significant difference as compared with that of the other three groups (P〈0.05); decreased TH immunoreactivity (377.0±41.6) cells/mm2) and increased α-synuclein immunoreactivity (0.75±0.02) in the SNc of rats in the rotenone group was noted,enjoying significant differences as compared with the other three groups (P〈0.05); these values in the rotenone+candesartan cilexetil group were (337.2±26.3) g,(639.7±46.0) cells/mm2 and 0.57±0.01,respectively (P〈0.05).Western blotting confirmed that rotenone up-regulated the expression ofα-synuclein in the SNc,and candesartan ceilexetil markedly attenuated the increase (P〈0.05).Conclusion Candesartan cilexetil can protect rotenone-induced PD in rats through decreasing TH-positive cell apoptosis and α-synuclein deposition.
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2014年第9期894-898,共5页 Chinese Journal of Neuromedicine
基金 国家自然科学基金(81271418) 江苏省自然科学基金(BK201254)
关键词 帕金森病 鱼藤酮 坎地沙坦酯 Parkinson's disease Rotenone Candesartan cilexetil
  • 相关文献

参考文献13

  • 1Olanow CW, Stem MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009)[J]. Neurology, 2009, 72(21 Suppl 4): S1-S136.
  • 2Obeso JA, Rodriguez-Oroz MC, Goetz CG, et al. Missing pieces in the Parkinson's disease puzzle[J]. Nat Med, 2010, 16(6): 653-661.
  • 3ViUar-Cheda B, Dominguez-Meijide A, Joglar B, et al. Involvement of microglial RhoA/Rho-Kinase pathway activation in the dopaminergic neuron death. Role of angiotensin via angiotensin type 1 receptors[J]. Neurobiol Dis, 2012, 47(2): 268-279.
  • 4Mertens B, Varcin M, Michotte Y, et al. The neuroprotective action of candesartan is related to interference with the early stages of 6-hydroxydopamine-induced dopaminergic cell death [J]. Eur J Neurosci, 2011, 34(7): 1141-1148.
  • 5陈忻,张楠,赵晖,穆阳.鱼藤酮致帕金森病大鼠行为学与黑质病理损伤的关系[J].中国神经精神疾病杂志,2008,34(4):232-234. 被引量:76
  • 6Wright JW, Harding JW. Importance of the brain Angiotensin system in Parkinson's disease[J]. Parkinsons Dis, 2012: 860923.
  • 7Fu H, Hosomi N, Pelisch N, et al. Therapeutic effects ofpostischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia [J]. J Hypertens, 2011, 29(11): 2210-2219.
  • 8Joglar B, Rodriguez-Pallares J, Rodriguez-Perez AI, et al. The inflammatory response in the MPTP model of Parkinson's disease is mediated by brain angiotensin: relevance to progression of the disease[J]. J Neurochem, 2009, 109(2): 656-669.
  • 9曹丽丹,杨亚萍,郑慧芬,洪雨,柯国秀,胡丽芳,刘春风.多巴胺能神经元对鱼藤酮敏感性的增龄改变及其机制[J].中华神经医学杂志,2011,10(11):1101-1105. 被引量:1
  • 10陈世文,孙元林,曾志芬,陶恩祥.利福平对鱼藤酮诱导的分化PC12细胞线粒体损伤的保护作用[J].中华神经医学杂志,2009,8(9):907-910. 被引量:2

二级参考文献42

  • 1冯媛,梁直厚,王涛,乔娴,孙莉,刘红进,孙圣刚.鱼藤酮帕金森病大鼠模型建立的研究[J].卒中与神经疾病,2004,11(6):374-377. 被引量:20
  • 2赵喜林,顾振纶,秦正红.长期低剂量皮下注射鱼藤酮制作大鼠帕金森病模型[J].中国药理学通报,2005,21(10):1274-1277. 被引量:27
  • 3郭续文,徐如祥,姜晓丹,邹志浩,蔡颖谦,杜谋选,秦玲莎,邹雨汐.利福平保护MPTP所致PD小鼠中脑多巴胺能神经元凋亡的实验研究[J].中华神经医学杂志,2006,5(6):546-549. 被引量:6
  • 4Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis[J]. Nat Clin Pract Neurol, 2008, 4(11): 600-609.
  • 5Ubhi K, Rockenstein E, Mante M, et al. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy[J]. Neuroreport, 2008, 19(13): 1271-1276.
  • 6Xu J, Wei C, Xu C, et al. Rifampicin protects PC12 cells against MPP^+-induced apoptosis and inhibits the expression of an α-synuclein multimer[J]. Brain Res, 2007, 1139: 220-225.
  • 7Testa CM, Sherer TB, Greenamyre JT. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substania nigra cultures[J]. Brain Res Mol Brain Res, 2005, 134(1): 109-118.
  • 8Kapumiotu A. Targeting alpha-synuclein in Parkinson's disease[J]. Chem Biol, 2004, 11(11): 1476-1478.
  • 9Volles MJ, Lansbury PT Jr. Zeroing in on the pathogenic form of alpha-synuclein and its mechanism of neurotoxieity in Parkinson's disease[J]. Biochemistry, 2003, 42(26): 7871-7878.
  • 10Oida Y, Kitaichi K, Nakayama H, et al. Rifampicin attenuates the MPTP-induced neurotoxicity in mouse brain[J]. Brain Res, 2006, 1082(1): 196-204.

共引文献76

同被引文献17

引证文献2

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部